GNI GROUP LTD.
Contact Us
About Us
About Us TOP
Message
Business Model
Main Products
Management Policy
Company Overview
Board of Directors
Main Group Structure
Office
Corporate governance
R&D
R&D TOP
Pipeline
Discovery Research
Research publications
Investor Relations
Investor Relations TOP
IR News
Information
IR Materials
IR Calendar
IR Email Subscription
Electronic Public Notices
Sustainability/ESG
Sustainability/ESG TOP
Sustainability Initiatives
ESG Data
Contact Us
Site Map
Privacy Policy
Terms of Use
ソーシャルメディアポリシー
2014's Information
トップページ
Information
2014年
All
2025
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2014/12/12
Filing of IND for Connective Tissue Disease Associated Interstitial Lung Disease
2014/11/10
Beijing Continent Pharmaceutical Co, Ltd.(our subsidiary company)will attend 2014 APSR.
2014/10/08
Quick View from EDISON
2014/09/29
Notice of Exercise Price of Stock Option etc
2014/09/12
Notice of Granting Stock Option to Board of Directors
2014/09/04
Tokyo Administrative Office Relocation
2014/09/01
Re-assignment of Industry Category
2014/07/01
F351 Phase II Clinical Trial Approval
2014/06/11
World Orphan Drug Congress Asia
2014/05/09
Patent Allowance for Etuary and F351 in the U.S.
1
2
3
>